The FDA on Aug. 21 approved Pfizer’s maternal vaccine meant to protect infants from respiratory syncytial virus.
Read the full post on Becker's Hospital Review - Healthcare News
FDA clears Pfizer's maternal RSV shot for newborns
The FDA on Aug. 21 approved Pfizer’s maternal vaccine meant to protect infants from respiratory syncytial virus.
Read the full post on Becker's Hospital Review - Healthcare News